Potassium infusion and atrial fibrillatio

• Conditions: Atrial fibrillation / atrial flutter; Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]

• Registration Number: EUCTR2011-005525-48-NO
• Lead Sponsor: Diakonhjemmet hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-05-10
• Last Update Posted: 22 October 2012

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

- Paroxysmal atrial fibrillation/ atrial flutter with duration < 48 hours.
- Serum-potassium = 4,0 mmol/l.

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 100
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 100

Exclusion Criteria

- Kidney failure with eGFR <30ml/min
- Patients with ongoing treatment with anti arrhythmic drugs (flecainide, amiodarone, dronedarone or sotalol).

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified